NextSeq 1000

Key Dates
Due Date

-

Posted Date

-

Agency & Value
Agency

ARMY MED RES ACQ ACTIVITY

Contract Value

Not provided

Codes & Classification
Solicitation Number

FY26-0778

NAICS

334516 - Analytical Laboratory Instrument Manufacturing

Classification Code

6515

Additional Details
Set Aside

NONE

Place of Performance

Dover AFB, Delaware, UNITED STATES

SourceSAM
Documents1
The Defense Health Agency Contracting Activity (DHACA), operating out of Fort Detrick, Maryland, has issued a presolicitation notice indicating its intent to negotiate a sole source procurement with Illumina, Inc. for the acquisition of the NextSeq 1000 Sequencing System. This procurement is being conducted in accordance with Federal Acquisition Regulation (FAR) 12.102(a), which allows for sole source acquisitions when only one responsible source is capable of fulfilling the agency’s requirements. The NextSeq 1000 Sequencing System is a critical piece of equipment for the Armed Forces Medical Examiner System DNA Operations (AFMES-DNA OPS), located at Dover Air Force Base, Delaware. The system supports the AFMES-DNA OPS mission by providing a fast, integrated DNA-to-analysis workflow. Its capabilities include rapid sequencing of targeted panels, whole mitochondrial genomes, and single nucleotide polymorphism (SNP) analysis within a single run. These features are essential for the operational needs of the AFMES-DNA OPS, and Illumina, Inc. is identified as the only vendor able to provide this specific sequencing system. This acquisition falls under the North American Industry Classification System (NAICS) code 334516, which pertains to Analytical Laboratory Instrument Manufacturing, with a small business size standard of 1,000 employees. The Product Service Code (PSC) associated with this procurement is 6515, which covers medical and surgical instruments, equipment, and supplies. There are no set-aside restrictions for this requirement; it is open to all qualified sources, though the government has determined that only Illumina, Inc. can meet the technical requirements at this time. The presolicitation notice clarifies that this is not a request for competitive proposals, and no formal solicitation document exists. However, interested parties who believe they can provide a technically equivalent solution are invited to submit capability statements, including technical data and cost information, to demonstrate their ability to meet the government’s needs. All submissions will be reviewed for the sole purpose of determining whether a competitive procurement is feasible. The government reserves the right to make a final determination regarding competition based on the responses received. The place of performance for this procurement is Dover Air Force Base in Delaware, United States. The contracting entity responsible for this action is the Army Medical Research Acquisition Activity, a federal office under the Department of Defense and the Defense Health Agency. Interested vendors should direct their capability statements and any related inquiries to Alicia Maldonado Torres at [email protected]. Submissions must be received no later than 12:00 P.M. EST on July 1, 2026. No phone inquiries will be accepted. This notice was originally posted on June 29, 2026, and further details, including the official posting and any attachments, can be accessed via the SAM.gov opportunity ID 4b7dd0d00eba438fb5f47fe63a0fa890. In summary, this procurement seeks to secure the NextSeq 1000 Sequencing System from Illumina, Inc. to support critical DNA analysis operations at Dover AFB. The government has identified Illumina as the only source capable of meeting the technical requirements, but will consider capability statements from other interested parties prior to finalizing the sole source determination.